You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

mfolfox6

Showing 1 - 25 of 38
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Colorectal Cancer Trial in Guangzhou (mFOLFOXIRI + Cadonilimab, mFOLFOX6)

Not yet recruiting
  • Colorectal Cancer
  • mFOLFOXIRI + Cadonilimab
  • mFOLFOX6
  • Guangzhou, Guangdong, China
    Gastrointestinal Hospital, Sun Yat-sen University
Oct 17, 2022

Colorectal Cancer Trial (mFOLFOXIRI, mFOLFOX6)

Not yet recruiting
  • Colorectal Cancer
  • (no location specified)
Jun 17, 2022

CRC Trial (HLX07, HLX10, mFOLFOX6)

Not yet recruiting
  • CRC
  • (no location specified)
May 1, 2022

Gastric Cancer Trial in Worldwide (Varlitinib, mFOLFOX6, Placebo)

Completed
  • Gastric Cancer
  • Tallinn, Estonia
  • +15 more
Feb 14, 2022

Metastatic Colorectal Cancer Trial in Sutton (PDR001, bevacizumab, mFOLFOX6)

Terminated
  • Metastatic Colorectal Cancer
  • Sutton, Surrey, United Kingdom
    Novartis Investigative Site
Oct 7, 2021

Esophageal Carcinoma Trial in Rochester (mFOLFOX6, Chemoradiation)

Active, not recruiting
  • Esophageal Carcinoma
  • mFOLFOX6
  • Chemoradiation
  • Rochester, New York
    University of Rochester
Aug 17, 2022

Metastatic Colorectal Cancer (CRC) Trial (TRS003, China-approved Bevacizumab, mFOLFOX6)

Not yet recruiting
  • Metastatic Colorectal Cancer (CRC)
  • TRS003
  • +2 more
  • (no location specified)
May 12, 2022

Metastatic Colorectal Cancer Trial in Shanghai (Fruquintinib, FOLFIRI, mFOLFOX6)

Not yet recruiting
  • Metastatic Colorectal Cancer
  • Shanghai, Shanghai, China
    Department of Colorectal Surgery Fudan University Shanghai Caner
Nov 23, 2022

Colorectal Carcinoma Trial (mFOLFOX6, FOLFIRI, pembrolizumab)

Active, not recruiting
Has Results
  • Colorectal Carcinoma
  • mFOLFOX6
  • +4 more
  • (no location specified)
Oct 28, 2022

Colon Cancer, Colorectal Cancer, Rectal Cancer Trial in Worldwide (Panitumumab, Bevacizumab, mFOLFOX6)

Completed
Has Results
  • Colon Cancer
  • +3 more
  • Birmingham, Alabama
  • +94 more
Nov 10, 2022

Metastatic Colorectal Cancer Trial in United States (mFOLFOX6, MVA-BN-CV301, FPV-CV301)

Active, not recruiting
  • Metastatic Colorectal Cancer
  • mFOLFOX6
  • +3 more
  • Duarte, California
  • +6 more
Jan 18, 2023

Patients With Resected Stage II Colon Cancer Trial in Dijon (mFOLFOX6)

Recruiting
  • Patients With Resected Stage II Colon Cancer
  • mFOLFOX6
  • Dijon, France
    Fédération Francophone de Cancérologie Digestive
Oct 21, 2021

Rectal Cancer Trial in Korea, Republic of (radiation, drug, procedure)

Recruiting
  • Rectal Cancer
  • short-course radiotherapy
  • +3 more
  • Daegu, Korea, Republic of
  • +8 more
Jan 8, 2023

Rectal Adenocarcinoma Trial in Chapel Hill (other, radiation, drug)

Withdrawn
  • Rectal Adenocarcinoma
  • Chemoradiation
  • +4 more
  • Chapel Hill, North Carolina
    Lineberger Comprehensive Cancer Center at University of North Ca
Nov 2, 2021

Colorectal Cancer Trial in Atlanta, Indianapolis, Columbus (Pembrolizumab, mFOLFOX6)

Completed
Has Results
  • Colorectal Cancer
  • Atlanta, Georgia
  • +2 more
Feb 14, 2022

Colorectal Cancer Trial (Cetuximab, mFOLFOX6, FOLFIRI)

Not yet recruiting
  • Colorectal Cancer
  • (no location specified)
Apr 29, 2021

Pancreatic Cancer Metastatic Trial in Gainesville (Dasatinib, mFOLFOX6)

Completed
Has Results
  • Pancreatic Cancer Metastatic
  • Gainesville, Florida
    UF Health Cancer Center
Dec 3, 2020

Solid Tumors Trial in Grand Rapids, Houston, San Antonio (CRLX101, Bevacizumab, mFOLFOX6)

Terminated
  • Solid Tumors
  • Grand Rapids, Michigan
  • +2 more
May 26, 2020

Rectal Cancer Trial in Guangzhou (mFOLFOX6, Radiotherapy)

Unknown status
  • Rectal Cancer
  • mFOLFOX6
  • Radiotherapy
  • Guangzhou, Guangdong, China
    Gastrointestinal Hospital, Sun Yatsen University
Apr 30, 2020

Previously Untreated Pancreatic Ductal Adenocarcinoma, Relapsed/Refractory Pancreatic Ductal Adenocarcinoma Trial in United

Terminated
Has Results
  • Previously Untreated Pancreatic Ductal Adenocarcinoma
  • Relapsed/Refractory Pancreatic Ductal Adenocarcinoma
  • Scottsdale, Arizona
  • +8 more
Mar 31, 2021

Gastric Cancer, Gastroesophageal Junction Adenocarcinoma Trial in Worldwide (Bemarituzumab, Nivolumab, mFOLFOX6)

Recruiting
  • Gastric Cancer
  • Gastroesophageal Junction Adenocarcinoma
  • Phoenix, Arizona
  • +119 more
Feb 1, 2023

Metastatic Colon Cancer, Surgery Trial in Shanghai (resection of primary tumor, XELOX, mFOLFOX6)

Recruiting
  • Metastatic Colon Cancer
  • Surgery
  • resection of primary tumor
  • +2 more
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center
Jun 1, 2020

Gastric Cancer, Gastroesophageal Junction Adenocarcinoma Trial in Worldwide (Bemarituzumab, mFOLFOX6, Placebo)

Recruiting
  • Gastric Cancer
  • Gastroesophageal Junction Adenocarcinoma
  • Anchorage, Alaska
  • +140 more
Aug 11, 2022

Hepatocellular Carcinoma Trial in Hangzhou (Individualized Chemotherapy, mFOLFOX6)

Withdrawn
  • Hepatocellular Carcinoma
  • Individualized Chemotherapy
  • mFOLFOX6
  • Hangzhou, Zhejiang, China
    First affiliated hospital, Zhejiang University
Feb 13, 2020

Colorectal Tumors Trial in Shanghai (avastin, mFOLFOX6)

Completed
  • Colorectal Neoplasms
  • Shanghai, Shanghai, China
    Zhongshan Hospital, Fudan University
Dec 15, 2019